Fig. 9From: Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysisSimulation results for the variation of scenario 4 when fixed \(X_1 = 0\) (or \(X_1 = 1\)), if \(X_2\) changes, the hazard of relapse increases of 2 times (Case A) or of 1.5 times (Case B). The grey horizontal line is the reference null biasBack to article page